Literature DB >> 10453810

Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies.

R Clarke1, M Shipley, S Lewington, L Youngman, R Collins, M Marmot, R Peto.   

Abstract

In prospective studies, disease rates during follow-up are typically analyzed with respect to the values of factors measured during an initial baseline survey. However, because of "regression dilution," this generally tends to underestimate the real associations of disease rates with the "usual" levels of such risk factors during some particular exposure period. The "regression dilution ratio" describes the ratio of the steepness of the uncorrected association to that of the real association. To assess the relevance of the usual value of a risk factor during particular exposure periods (e.g., first, second, and third decades) to disease risks, regression dilution ratios can be derived by relating baseline measurements of the risk factor to replicate measurements from a reasonably representative sample of study participants after an interval equivalent to about the midpoint of each exposure period (e.g., at 5, 15, and 25 years, respectively). This report illustrates the impact of this time interval on the magnitude of the regression dilution ratios for blood pressure and blood cholesterol. The analyses were based on biennial remeasurements over 30 years for participants in the Framingham Study (Framingham, Massachusetts) and a 26-year resurvey for a sample of men in the Whitehall Study (London, England). They show that uncorrected associations of disease risk with baseline measurements underestimate the strength of the real associations with usual levels of these risk factors during the first decade of exposure by about one-third, the second decade by about one-half, and the third decade by about two-thirds. Hence, to correct appropriately for regression dilution, replicate measurements of such risk factors may be required at varying intervals after baseline for at least a sample of participants.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10453810     DOI: 10.1093/oxfordjournals.aje.a010013

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  261 in total

1.  Effect of serum insulin on the association between hyperuricemia and incident heart failure.

Authors:  Ravi V Desai; Mustafa I Ahmed; Gregg C Fonarow; Gerasimos S Filippatos; Michel White; Inmaculada B Aban; Wilbert S Aronow; Ali Ahmed
Journal:  Am J Cardiol       Date:  2010-10-15       Impact factor: 2.778

2.  Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy.

Authors:  Claude Béténé A Dooko; Stephane De Wit; Jacqueline Neuhaus; Adrian Palfreeman; Rosalie Pepe; James S Pankow; James D Neaton
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-15       Impact factor: 3.731

3.  Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study.

Authors:  Javed Butler; Andreas P Kalogeropoulos; Vasiliki V Georgiopoulou; Kirsten Bibbins-Domingo; Samer S Najjar; Kim C Sutton-Tyrrell; Tamara B Harris; Stephen B Kritchevsky; Donald M Lloyd-Jones; Anne B Newman; Bruce M Psaty
Journal:  Heart       Date:  2011-06-02       Impact factor: 5.994

Review 4.  Is blood pressure reduction a valid surrogate endpoint for stroke prevention? An analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the Biomarker-Surrogacy (BioSurrogate) Evaluation Schema (BSES).

Authors:  Marissa N Lassere; Kent R Johnson; Michal Schiff; David Rees
Journal:  BMC Med Res Methodol       Date:  2012-03-12       Impact factor: 4.615

5.  Once at risk--forever at risk? The long-term impact of cardiovascular risk factors on death.

Authors:  Hans-Werner Hense
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

6.  Impairment of activities of daily living and incident heart failure in community-dwelling older adults.

Authors:  C Barrett Bowling; Gregg C Fonarow; Kanan Patel; Yan Zhang; Margaret A Feller; Xuemei Sui; Steven N Blair; Kannayiram Alagiakrishnan; Inmaculada B Aban; Thomas E Love; Richard M Allman; Ali Ahmed
Journal:  Eur J Heart Fail       Date:  2012-04-04       Impact factor: 15.534

7.  Uncontrolled hypertension and increased risk for incident heart failure in older adults with hypertension: findings from a propensity-matched prospective population study.

Authors:  Anand S Iyer; Mustafa I Ahmed; Gerasimos S Filippatos; O James Ekundayo; Inmaculada B Aban; Thomas E Love; Navin C Nanda; George L Bakris; Gregg C Fonarow; Wilbert S Aronow; Ali Ahmed
Journal:  J Am Soc Hypertens       Date:  2010 Jan-Feb

8.  Cohort studies: history of the method. I. Prospective cohort studies.

Authors:  R Doll
Journal:  Soz Praventivmed       Date:  2001

9.  Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: a propensity-matched study of multimorbidity in chronic heart failure.

Authors:  Christine Ritchie; O James Ekundayo; Maureen Muchimba; Ruth C Campbell; Stuart J Frank; Bo Liu; Inmaculada B Aban; Ali Ahmed
Journal:  Int J Cardiol       Date:  2009-05-29       Impact factor: 4.164

10.  Novel circulating fatty acid patterns and risk of cardiovascular disease: the Cardiovascular Health Study.

Authors:  Fumiaki Imamura; Rozenn N Lemaitre; Irena B King; Xiaoling Song; Alice H Lichtenstein; Nirupa R Matthan; David M Herrington; David S Siscovick; Dariush Mozaffarian
Journal:  Am J Clin Nutr       Date:  2012-10-24       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.